Market research on the tissue and hygiene industry. Our reports f...
Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
Rx sales of adult incontinence continue to show strong growth in Kazakhstan in 2021. This primarily reflects the increase in average age of the population, as well as the fact that older consumers have been the most likely to be admitted to hospital…
The ongoing ageing of Denmark’s population continued to drive rising consumption, given that the elderly is the group most likely to experience incontinence. In addition, high obesity rates are also a factor driving value growth.
RX/reimbursement adult incontinence continued to decline in Italy in 2021 as a consequence of the spending review of the regional branches of the National Sanitary System. The Italian reimbursement scheme is an integral part of welfare assistance,…
RX/reimbursement adult incontinence is a more substantial category in Poland than retail adult incontinence and has continued to record stable demand during the pandemic. This was supported by an ageing population (with more older adults identifying…
In 2021, there were no changes to the regulatory frame regarding the number of incontinence products, per person, per year, that are covered by HZZO (Croatian medical system). Rules on subsidies are clearly stated in a legal guideline, which states…
Sales of Rx/reimbursement adult incontinence products continued to see solid volume growth in 2021, along with a slightly higher current value increase due to price rises. Like other hygiene categories, COVID-19 had little impact on the growth rates,…
Coronavirus (COVID-19) was deemed to have had a limited impact on Rx/reimbursement adult incontinence in Norway. This was mainly because these products are prescribed. Therefore, lockdown and home seclusion, the rising preventive health trend and…
Erosion of taboos and increasing consumer awareness benefit the product area
The pandemic did not have a major impact on Rx/reimbursement adult incontinence, as the product is essential, and in 2021, it registered healthy current value and volume growth. Moderate/heavy adult incontinence products performed better than light,…
There is no presence of Rx/reimbursement adult incontinence in Malaysia in 2021 and no indication that this will change in the forecast period.
Heightened health awareness, the expanding consumer base for incontinence products, as well as pandemic-induced rising enrolment in Medicaid, a critical safety net for a vast vulnerable population during economic downturns, continued to drive…
Rx/reimbursement incontinence in Australia is administered through the Continence Aids Payment Scheme (CAPS) offered by the Australian government. This is a non-taxable payment paid either annually or twice a year to cover some of the costs of…
Rx/reimbursement adult incontinence registered both current value and volume growth in 2021. However, growth was lower than in 2020, as hospitals treated less older patients with COVID-19, who also suffered from incontinence issues. The Institute of…
Value sales of Rx/reimbursement adult incontinence have seen slightly slower growth since the outbreak of COVID-19, with the pandemic creating some short-term disruptions to access, with some consumers facing difficulty accessing healthcare…
Hungary’s ageing population provided opportunity for further category growth in 2021. The majority of people with incontinence visit the doctor only when the problem is quite severe, which means that education is important in terms of how they may…
The fact that Rx/reimbursement adult incontinence products are available free of charge through Sweden’s public healthcare system and generally considered necessities by those who use them has helped to shield this category from the fallout of the…
Rx/reimbursement adult incontinence was largely unaffected by the pandemic, as it is an essential product. In 2021, volume growth was on par with 2020, though value growth was higher, due to price rises. Moderate/heavy adult incontinence products…
With consumer behaviour returning to normal again in 2021, Rx/reimbursement incontinence recorded stronger growth. Being more active and away from home increased the need for incontinence products overall. Additionally, more consumers were willing to…
Rx/reimbursement adult incontinence recorded an upturn in demand over the course of 2021, driven by increasing price sensitivity as consumers looked to save money wherever possible, in addition to greater awareness of their entitlement to these…